Lv4
408 积分 2023-08-07 加入
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
1天前
待确认
Efficacy and safety of Chaihuang Tongluo oral liquid in patients with chronic kidney disease: A single-center, randomized, open-label, controlled trial
1天前
已完结
Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial
1天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
14天前
已完结
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
14天前
已完结
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications
1个月前
已完结
Gestational Diabetes Mellitus and Accelerated Biological Aging in Middle-Aged and Elderly Women
2个月前
已完结
Maternal type 1 diabetes and relative protection against offspring transmission
2个月前
已完结
Sarcoidosis
3个月前
已完结
Ocular Sarcoidosis
3个月前
已完结
皖公网安备34019202002308
